Back to Search
PETER SCHOLZ, MD
MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1255400719Individual
Specialties, Licenses & Credentials
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
25MA04240800(NJ)
Research & Publications (20)
Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes.
PMID 19298539·Clin Exp Pharmacol Physiol·2009
7-preclinical
SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
PMID 19258738·Pharmacology·2009
7-preclinical
Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion.
PMID 18453749·Cell Physiol Biochem·2008
7-preclinical
[Investigations concerning the head-trunk-coordination].
PMID 18046663·Laryngorhinootologie·2008
8-other
Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
PMID 17595525·Cell Physiol Biochem·2007
7-preclinical
Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium.
PMID 17519532·Pharmacology·2007
7-preclinical
The serine protease HhoA from Synechocystis sp. strain PCC 6803: substrate specificity and formation of a hexameric complex are regulated by the PDZ domain.
PMID 17616590·J Bacteriol·2007
8-other
Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes.
PMID 17482833·Pharmacol Res·2007
7-preclinical
Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
PMID 17312451·J Cardiovasc Pharmacol·2007
7-preclinical
Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
PMID 16600302·J Surg Res·2006
7-preclinical
Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
PMID 16626695·Eur J Pharmacol·2006
7-preclinical
T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
PMID 16762459·Peptides·2006
7-preclinical
Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
PMID 16545395·J Surg Res·2006
7-preclinical
Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes.
PMID 16276122·Pharmacology·2006
7-preclinical
Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
PMID 16831448·Life Sci·2006
7-preclinical
Negative inotropic effect of low-dose ethanol in mouse ventricular myocytes is mediated by activation of endothelial nitric oxide synthase.
PMID 16116340·J Cardiovasc Pharmacol·2005
7-preclinical
Peripheral arterial cannulation for Abiomed BVS 5000 left ventricular assist device support.
PMID 16143275·J Heart Lung Transplant·2005
5-case
Atrial natriuretic peptide reverses the negative functional effects of stunning in rabbit myocardium.
PMID 16223535·Regul Pept·2005
7-preclinical
Alterations in ventricular myocyte contraction caused by C-type natriuretic peptide and nitric oxide in eNOS-/- mice.
PMID 16236310·J Mol Cell Cardiol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 125 PATERSON ST, SUITE 4100
NEW BRUNSWICK, NJ 08901 - Phone
- (732) 235-7800
Quick Facts
- NPI
- 1255400719
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile